Granted Patent
B2
US 8,614,185 · App. 12/768,093 · Granted Dec 24, 2013
Fusion proteins of alpha-MSH derivatives and Fc
Assignee:
Centocor Ortho Biotech Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to melanocortin receptor binding conjugates and methods of making and using the foregoing.
Claims (4)
1. An alpha-MSH derivative-Fc conjugate,
wherein the alpha-MSH derivative has a structure shown in Formula X (SEQ ID NO: 18), and the alpha-MSH derivative is coupled to the Fc via a hydrazine linker.
2. The alpha-MSH derivative-Fc conjugate of claim 1 , wherein the Fc is derived from an IgG1 Fc of SEQ ID NO: 2 or an IgG4 Fc of SEQ ID NO: 3.
3. A pharmaceutical composition comprising the alpha-MSH derivative-Fc conjugate of claim 1 in combination with a pharmaceutically acceptable carrier.
Assignments (2)
CHANGE OF NAME
Recorded Oct 23, 2013
From: CENTOCOR ORTHO BIOTECH INC.
To: JANSSEN BIOTECH, INC.
Reel/Frame 031476/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 22, 2010
From: HEAVNER, GEORGE
To: CENTOCOR ORTHO BIOTECH INC.
Reel/Frame 024722/0781 →
Continuity (3)
Provisional Application
61175921
· May 6, 2009
Provisional Application
61176294
· May 7, 2009